Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Financial Results

📢 Key Event
Jagsonpal to host Q1 FY27 earnings conference call on July 30, 2026

💡 Investor Takeaway
The call provides a platform for investors to hear management discuss quarterly performance and future outlook.

Jagsonpal Pharmaceuticals announced an investor conference call on July 30, 2026, to discuss Q1 FY27 financial results, inviting analysts and institutional investors to participate in the discussion of its upcoming earnings release.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"What are the expected revenue and profit figures for Q1 FY27?" "How does this quarter's performance compare to the previous year?" "What risks are highlighted for Jagsonpal's future growth?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 22 July 2026

PIRAMALFIN Piramal Finance Limited Financial Results HBSL HB Stockholdings Limited Annual Report SPLIL SPL Industries Limited Annual Report VIJAYA Vijaya Diagnostic Centre Limited Corporate Action BEL Bharat Electronics Limited Financial Results SIS SIS LIMITED Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day